Marker Therapeutics, Inc. (MRKR)

1.45 -0.05 (-3.33%) USD  |  NASDAQ  |  Feb 20, 16:00
1.46 +0.01 (+0.69%) Pre-Market: 20:00
More

Marker Therapeutics EBIT (TTM)

EBIT (TTM) Chart

View EBIT (TTM) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (TTM) Range, Past 5 Years

View EBIT (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (TTM) Benchmarks

View EBIT (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade